Combination immune checkpoint blockade has demonstrated promising benefit in lung
cancer, but predictors of response to combination therapy are unknown. Using whole-exome …

Background Inhibition of programmed death-ligand 1 (PD-L1) with atezolizumab can induce
durable clinical benefit (DCB) in patients with metastatic urothelial cancers, including …

Background The diagnosis of infective endocarditis (IE) can be difficult, particularly if blood
cultures fail to yield a pathogen. This study evaluates the potential utility of microbial cell-free …

Microbial cell-free DNA (mcfDNA) sequencing is an emerging infectious disease diagnostic
tool which enables unbiased pathogen detection and quantification from plasma. The Karius …

Robust quantification of immune cell infiltration into the tumor microenvironment may shed
light on why only a small proportion of patients benefit from checkpoint therapy. The immune …

Background Timely pathogen identification is critical for meaningful disease surveillance to
facilitate effective public health responses. However, public health important pathogens are …

Background: Inhibition of programmed death-ligand one (PD-L1) with atezolizumab can
induce durable clinical benefit (DCB) in patients with metastatic urothelial cancers, including …

The PlaceIQ platform is a large-scale data analysis system created on the concept of location.
This paper is a system overview where we provide an description of the nature of the data …

DataSpace: Analysis of Mach4 Muon Tracking for the BOREXINO Collaboration's Time-of-Flight
Precision Measurement of CNGS Neutrinos Skip navigation DataSpace About Contact Help …

… In preparing this new edition, I am grateful to Eliza Chang, Judie Ku and their colleagues at
Airiti Press for their most friendly and efficient help, and to Linsong Li for his kind assistance. …